These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31272272)

  • 1. Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease.
    Matsuguma C; Wakiguchi H; Suzuki Y; Okada S; Furuta T; Ohnishi Y; Azuma Y; Ohga S; Hasegawa S
    Scand J Rheumatol; 2019 Nov; 48(6):491-496. PubMed ID: 31272272
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
    Ye Q; Gong FQ; Shang SQ; Hu J
    Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease.
    Wakiguchi H; Hasegawa S; Suzuki Y; Kudo K; Ichiyama T
    Pediatr Res; 2015 Apr; 77(4):536-40. PubMed ID: 25580740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes/macrophages during acute Kawasaki disease.
    Ichiyama T; Ueno Y; Hasegawa M; Ishikawa Y; Matsubara T; Furukawa S
    Rheumatology (Oxford); 2005 Mar; 44(3):314-7. PubMed ID: 15572393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Immunoglobulin Therapy Restores the Quantity and Phenotype of Circulating Dendritic Cells and CD4
    Wang N; Chen Z; Zhang F; Zhang Q; Sun L; Lv H; Wang B; Shen J; Zhou X; Chen F; Zhang B; Meng L; Zhou H; Bai Z; Huang J
    Front Immunol; 2022; 13():802690. PubMed ID: 35222381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab regulates monocytes and regulatory T cells in Kawasaki disease.
    Koizumi K; Hoshiai M; Katsumata N; Toda T; Kise H; Hasebe Y; Kono Y; Sunaga Y; Yoshizawa M; Watanabe A; Kagami K; Abe M; Sugita K
    Pediatr Int; 2018 Sep; 60(9):796-802. PubMed ID: 29543362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of CD4⁺CD25⁺FOXP3⁺ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease.
    Hirabayashi Y; Takahashi Y; Xu Y; Akane K; Villalobos IB; Okuno Y; Hasegawa S; Muramatsu H; Hama A; Kato T; Kojima S
    Eur J Pediatr; 2013 Jun; 172(6):833-7. PubMed ID: 23340699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.
    McAlpine SM; Roberts SE; Heath JJ; Käsermann F; Issekutz AC; Issekutz TB; Derfalvi B
    Front Immunol; 2021; 12():660506. PubMed ID: 34093549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
    Ge X; Li CR; Yang J; Wang GB
    Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictive value of peripheral blood lymphocyte subsets for children with intravenous immunoglobulin-resistant Kawasaki disease].
    Xue Y; Yin J; Xu L; Dang LH; Wang C; Cui YQ; Zhang XJ; Li CW
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Dec; 25(12):1211-1218. PubMed ID: 38112137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "Intermediate" CD14 + CD16 + monocyte subpopulation plays a role in IVIG responsiveness of children with Kawasaki disease.
    Kim YS; Yang HJ; Kee SJ; Choi I; Ha K; Ki KK; Jeong IS; Cho HJ
    Pediatr Rheumatol Online J; 2021 May; 19(1):76. PubMed ID: 34059085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin.
    Burns JC; Song Y; Bujold M; Shimizu C; Kanegaye JT; Tremoulet AH; Franco A
    Clin Exp Immunol; 2013 Dec; 174(3):337-44. PubMed ID: 23901839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease.
    Burns JC; Touma R; Song Y; Padilla RL; Tremoulet AH; Sidney J; Sette A; Franco A
    Autoimmunity; 2015 May; 48(3):181-8. PubMed ID: 25822882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating CD4+CD8+ T lymphocytes in patients with Kawasaki disease.
    Hirao J; Sugita K
    Clin Exp Immunol; 1998 Feb; 111(2):397-401. PubMed ID: 9486410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intravenous immunoglobulin on lymphocyte populations in children with Kawasaki syndrome.
    Saulsbury FT
    Clin Exp Rheumatol; 1992; 10(6):617-20. PubMed ID: 1483316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S; Kawashima H; Kashiwagi Y; Hoshika A
    Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in CD69, CD25 and HLA-DR expressions in peripheral blood T cells in Kawasaki disease].
    Zhang YY; Huang XM; Kang ML; Gong FQ; Qian BQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):329-32. PubMed ID: 16780706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulatory changes in Kawasaki disease.
    Jason J; Gregg L; Han A; Hu A; Inge KL; Eick A; Tham I; Campbell R
    Clin Immunol Immunopathol; 1997 Sep; 84(3):296-306. PubMed ID: 9281389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher efficacy of infliximab than immunoglobulin on Kawasaki disease, a meta-analysis.
    Li X; Tang Y; Ding Y; Chen Y; Hou M; Sun L; Qian G; Qin L; Lv H
    Eur J Pharmacol; 2021 May; 899():173985. PubMed ID: 33652059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease.
    Wang CL; Wu YT; Liu CA; Lin MW; Lee CJ; Huang LT; Yang KD
    Pediatrics; 2003 Feb; 111(2):E140-7. PubMed ID: 12563087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.